147 related articles for article (PubMed ID: 6974163)
21. In vitro activity of midecamycin against Staphylococcus aureus.
Peng CF; Chen TS
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Mar; 12(1):32-3. PubMed ID: 583273
[No Abstract] [Full Text] [Related]
22. In vitro and in vivo antibacterial activities of clarithromycin.
Ono T; Numata K; Nagate T; Mitsuhashi S; Inoue M
Chemotherapy; 1996; 42(3):159-69. PubMed ID: 8983882
[TBL] [Abstract][Full Text] [Related]
23. [In vitro activity of roxithromycin compared to 5 other macrolides against staphylococci].
Brun Y; Coulet M; Forey F; Fleurette J
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):613-8. PubMed ID: 3054736
[TBL] [Abstract][Full Text] [Related]
24. Studies of tylosin derivatives effective against macrolide-resistant strains: synthesis and structure-activity relationships.
Tsuchiya M; Hamada M; Takeuchi T; Umezawa H; Yamamoto K; Tanaka H; Kiyoshima K; Mori S; Okamoto R
J Antibiot (Tokyo); 1982 Jun; 35(6):661-72. PubMed ID: 7118722
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
[TBL] [Abstract][Full Text] [Related]
26. [Clinical evaluation of josamycin for the treatment of Mycoplasma pneumonia in children].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Ishimoto K; Tominaga K
Jpn J Antibiot; 1983 Jun; 36(6):1359-76. PubMed ID: 6418931
[TBL] [Abstract][Full Text] [Related]
27. The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel G; Oriel JD
J Antimicrob Chemother; 1983 Nov; 12(5):511-4. PubMed ID: 6608516
[TBL] [Abstract][Full Text] [Related]
28. [In vitro activity of josamycin in a comparison of Staphylococcus aureus, Streptococcus pyogenes and Streptococcus pneumoniae].
Andreoni O
Minerva Med; 1983 Mar; 74(12):619-24. PubMed ID: 6339995
[TBL] [Abstract][Full Text] [Related]
29. Biological properties of new acyl derivatives of tylosin.
Okamoto R; Tsuchiya M; Nomura H; Iguchi H; Kiyoshima K; Hori S; Inui T; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1309-15. PubMed ID: 7251472
[TBL] [Abstract][Full Text] [Related]
30. Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
Shadomy S; Tipple M; Paxton L
Antimicrob Agents Chemother; 1976 Oct; 10(4):773-5. PubMed ID: 984811
[TBL] [Abstract][Full Text] [Related]
31. Sub-inhibitory and post-antibiotic effects of spiramycin and erythromycin on Staphylococcus aureus.
Webster C; Ghazanfar K; Slack R
J Antimicrob Chemother; 1988 Jul; 22 Suppl B():33-9. PubMed ID: 3182445
[TBL] [Abstract][Full Text] [Related]
32. [Postantibiotic effects (PAE's) of macrolide antibiotics evaluated using Bioscreen C method].
Okubo T; Suzuki T; Fujita K; Iyobe S; Inoue M
Jpn J Antibiot; 1995 Apr; 48(4):548-52. PubMed ID: 7783317
[TBL] [Abstract][Full Text] [Related]
33. [Synergism of josamycin and oxidation against Staphylococcus aureus].
Labro MT; el Benna J
Pathol Biol (Paris); 1990 May; 38(5):450-4. PubMed ID: 2164183
[TBL] [Abstract][Full Text] [Related]
34. [Resistance to macrolide antibiotics found in methicillin-resistant Japanese clinical isolates of Staphylococcus aureus in 1996].
Nakamura A; Taniguchi K; Tsurubuchi K; O'Hara K; Sawai T
Jpn J Antibiot; 1998 Jul; 51(7):494-500. PubMed ID: 9755433
[TBL] [Abstract][Full Text] [Related]
35. [In vitro examination on antibacterial activity of ciclacillin (ACPC) against clinically isolated strains (author's transl)].
Deguchi K
Jpn J Antibiot; 1977 May; 30(5):315-20. PubMed ID: 17021
[TBL] [Abstract][Full Text] [Related]
36. [In vitro activity of miocamycin compared with four other macrolides and with pristinamycin against Branhamella catarrhalis].
Suermondt G; Denamur E; Fleuret A; Laurans G; Orfila J
Pathol Biol (Paris); 1989 May; 37(5):386-9. PubMed ID: 2506513
[TBL] [Abstract][Full Text] [Related]
37. Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells.
Misu T; Arai S; Furukawa M; Yamamoto Y; Miyazaki T
Antimicrob Agents Chemother; 1987 Nov; 31(11):1843-5. PubMed ID: 3124740
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of midecamycin, a new macrolide antibiotic.
Neu HC
Antimicrob Agents Chemother; 1983 Sep; 24(3):443-4. PubMed ID: 6639001
[TBL] [Abstract][Full Text] [Related]
39. Medical implications of macrolide resistance and its relationship to the use of tylosin in animal feeds.
Knothe H
Infection; 1977; 5(3):137-9. PubMed ID: 914361
[TBL] [Abstract][Full Text] [Related]
40. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
